UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity

Scientific reports, 2013-12, Vol.3 (1), p.3544-3544, Article 3544

2013

Volltextzugriff (PDF)

MicroRNAs as prognostic markers in ovarian cancer

Molecular and cellular endocrinology, 2014-06, Vol.390 (1-2), p.73-84

2014

Volltextzugriff (PDF)

Update on novel therapeutic agents for cervical cancer

Gynecologic oncology, 2008-09, Vol.110 (3), p.S72-S76

2008

Volltextzugriff (PDF)

New challenges for molecular oncology in ovarian carcinoma

Medicina clínica, 2007-01, Vol.128 (1), p.15-17

2007

Volltextzugriff (PDF)

A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer

Gynecologic oncology, 2016-07, Vol.142 (1), p.62-69

2016

Volltextzugriff (PDF)

Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study

Journal of clinical oncology, 2016-03, Vol.34 (7), p.706-713

2016

Volltextzugriff (PDF)

Pembrolizumab in recurrent advanced cervical squamous carcinoma

Immunotherapy, 2017-05, Vol.9 (6), p.467-470

2017

Volltextzugriff (PDF)

Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls

Clinical & translational oncology, 2012, Vol.14 (1), p.15-20

2012

Volltextzugriff (PDF)

Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab‐based therapy

Head & neck, 2008-05, Vol.30 (5), p.680-683

2008

Volltextzugriff (PDF)

Nuevos retos de la oncología molecular en el cáncer de ovario

Medicina clínica, 2007, Vol.128 (1), p.15-17

2007

Volltextzugriff (PDF)

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer

Journal of clinical oncology, 2016-12, Vol.34 (36), p.4345-4353

2016

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of Weekly 1-Hour and 24-Hour Infusion BMS-214662, a Farnesyltransferase Inhibitor, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2521-2533

2005

Volltextzugriff (PDF)

ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity

Scientific reports, 2015-02, Vol.5 (1), p.8179-8179, Article 8179

2015

Volltextzugriff (PDF)

Abstract B15: Unveiling the mechanism of ovarian cancer dissemination through a comparative study among primary tumors, ascites and metastases

Clinical cancer research, 2013-10, Vol.19 (19_Supplement), p.B15-B15

2013

Volltextzugriff (PDF)

Abstract A28: Analyses of FOXM1 isoforms in ovarian cancer

Clinical cancer research, 2013-10, Vol.19 (19_Supplement), p.A28-A28

2013

Volltextzugriff (PDF)

Abstract A56: Identification of a micro RNA profile to predict response to therapy and improve patient survival in ovarian cancer

Clinical cancer research, 2013-10, Vol.19 (19_Supplement), p.A56-A56

2013

Volltextzugriff (PDF)

ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

Radiotherapy and oncology, 2015-12, Vol.117 (3), p.559-581

2015

Volltextzugriff (PDF)

Prognostic role of CA-125 nadir in stage IV epithelial ovarian cancer

Journal of clinical oncology, 2008-04, Vol.26 (10), p.1771-1772

2008

Volltextzugriff (PDF)

Nuevos retos de la oncología molecular en el cáncer de ovario

Medicina clínica, 2007-01, Vol.128 (1), p.15-17

2007

Volltextzugriff (PDF)

Overexpression of c‐erbB‐2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy

Cancer, 1995-04, Vol.75 (8), p.2147-2152

1995

Volltextzugriff (PDF)

Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy

Head & Neck, 2008, Vol.30 (5), p.680-683

2008

Volltextzugriff (PDF)

Effects of two personalized dietary strategies during a 2‐year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial

Liver international, 2021-07, Vol.41 (7), p.1532-1544

2021

Volltextzugriff (PDF)

Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study

Nutrients, 2022-12, Vol.14 (23), p.5160

2022

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity

MicroRNAs as prognostic markers in ovarian cancer

Update on novel therapeutic agents for cervical cancer

New challenges for molecular oncology in ovarian carcinoma

A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer

Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study

Pembrolizumab in recurrent advanced cervical squamous carcinoma

Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls

Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab‐based therapy

Nuevos retos de la oncología molecular en el cáncer de ovario

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer

Phase I Pharmacokinetic and Pharmacodynamic Study of Weekly 1-Hour and 24-Hour Infusion BMS-214662, a Farnesyltransferase Inhibitor, in Patients With Advanced Solid Tumors

ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity

Abstract B15: Unveiling the mechanism of ovarian cancer dissemination through a comparative study among primary tumors, ascites and metastases

Abstract A28: Analyses of FOXM1 isoforms in ovarian cancer

Abstract A56: Identification of a micro RNA profile to predict response to therapy and improve patient survival in ovarian cancer

ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

Prognostic role of CA-125 nadir in stage IV epithelial ovarian cancer

Nuevos retos de la oncología molecular en el cáncer de ovario

Overexpression of c‐erbB‐2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy

Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE)

Effects of two personalized dietary strategies during a 2‐year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial

Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study

A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial

Suchergebnisse filtern